Group One Trading, L.P. Vanda Pharmaceuticals Inc. Transaction History

Group One Trading, L.P.

  • $3.01 Billion
  • Q2 2024

A detailed history of Group One Trading, L.P. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 94,256 shares of VNDA stock, worth $460,911. This represents 0.02% of its overall portfolio holdings.

Number of Shares
94,256
Previous 27,520 242.5%
Holding current value
$460,911
Previous $113,000 370.8%
% of portfolio
0.02%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$3.91 - $6.5 $260,937 - $433,784
66,736 Added 242.5%
94,256 $532,000
Q1 2024

May 10, 2024
BUY
$3.47 - $4.61 $86,618 - $115,074
24,962 Added 975.84%
27,520 $113,000
Q4 2023

Feb 14, 2024
BUY
$3.38 - $4.58 $1,875 - $2,541
555 Added 27.71%
2,558 $10,000
Q3 2023

Nov 09, 2023
BUY
$4.28 - $6.57 $8,144 - $12,502
1,903 Added 1903.0%
2,003 $8,000
Q1 2023

May 12, 2023
BUY
$6.18 - $7.99 $618 - $799
100 New
100 $0
Q2 2022

Aug 11, 2022
SELL
$9.31 - $11.84 $15,119 - $19,228
-1,624 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$10.84 - $16.55 $132,855 - $202,836
-12,256 Reduced 88.3%
1,624 $18,000
Q4 2021

Feb 11, 2022
BUY
$15.69 - $21.14 $188,860 - $254,462
12,037 Added 653.12%
13,880 $218,000
Q3 2021

Nov 12, 2021
SELL
$15.35 - $21.27 $158,473 - $219,591
-10,324 Reduced 84.85%
1,843 $32,000
Q2 2021

Aug 10, 2021
BUY
$15.71 - $21.51 $181,152 - $248,031
11,531 Added 1813.05%
12,167 $262,000
Q1 2021

May 12, 2021
SELL
$13.42 - $20.28 $38,730 - $58,528
-2,886 Reduced 81.94%
636 $10,000
Q4 2020

Feb 10, 2021
SELL
$9.77 - $13.81 $18,387 - $25,990
-1,882 Reduced 34.83%
3,522 $46,000
Q3 2020

Nov 12, 2020
BUY
$9.32 - $12.02 $49,396 - $63,706
5,300 Added 5096.15%
5,404 $52,000
Q2 2020

Aug 13, 2020
BUY
$9.66 - $12.02 $1,004 - $1,250
104 New
104 $1,000
Q1 2020

May 13, 2020
SELL
$7.5 - $16.8 $5,550 - $12,432
-740 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$12.38 - $17.47 $1,485 - $2,096
120 Added 19.35%
740 $12,000
Q3 2019

Nov 12, 2019
BUY
$12.27 - $15.79 $7,607 - $9,789
620 New
620 $8,000
Q4 2018

Feb 06, 2019
SELL
$18.97 - $31.47 $139,069 - $230,706
-7,331 Closed
0 $0
Q3 2018

Nov 08, 2018
BUY
$18.25 - $23.0 $133,790 - $168,613
7,331 New
7,331 $168,000
Q1 2018

May 11, 2018
SELL
$14.05 - $20.2 $34,577 - $49,712
-2,461 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$12.85 - $18.1 $31,623 - $44,544
2,461
2,461 $37,000

Others Institutions Holding VNDA

# of Institutions
154
Shares Held
44.6M
Call Options Held
136K
Put Options Held
220K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $277M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email